Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
12.11
+0.17 (1.42%)
At close: Jun 11, 2025, 4:00 PM
12.81
+0.70 (5.78%)
After-hours: Jun 11, 2025, 5:49 PM EDT
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $506.61 million as of June 11, 2025.
Market Cap
506.61M
Enterprise Value
195.46M
1-Year Change
n/a
Ranking
Category
Stock Price
12.11
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has decreased from $676.47M to $506.61M, a decrease of -25.11%. That is a compound annual growth rate of -32.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2025 | 499.50M | 45.94% |
| Dec 31, 2024 | 342.27M | -49.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 694.59B |
| Johnson & Johnson | 373.49B |
| AbbVie | 334.13B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.04B |
| Abbott Laboratories | 232.09B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.45B |